PHIO PHARMACEUTICALS CORP. Form ARS: Annual report to security holders
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-14: Form ARS; Period of report 2025-12-31; Description ANNUAL REPORT; Document phio_ars5.pdf.
- 2025-07-30: Form ARS; Period of report 2024-12-31; Description FORM ARS; Document phio_ars.pdf.
- 2024-05-08: Form ARS; Period of report 2023-12-31; Description ANNUAL REPORT TO SECURITY HOLDERS; Document phio_ars.pdf.
- 2023-06-09: Form ARS; Period of report 2022-12-31; Description ANNUAL REPORT TO SECURITY HOLDERS; Document phio_ars.pdf.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-14 | ARS | 2025-12-31 | ANNUAL REPORT | phio_ars5.pdf |
| 2025-07-30 | ARS | 2024-12-31 | FORM ARS | phio_ars.pdf |
| 2024-05-08 | ARS | 2023-12-31 | ANNUAL REPORT TO SECURITY HOLDERS | phio_ars.pdf |
| 2023-06-09 | ARS | 2022-12-31 | ANNUAL REPORT TO SECURITY HOLDERS | phio_ars.pdf |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |